Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 476-481

  Uyar, Cemile ^a   Akcam, Fusun Zeynep ^a   Ciris, Metin ^a   Kaya, Onur ^a   Kockar, Cem ^a   Isler, Mehmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

ActiTest; FibroTest; hepatitis B virus; hepatitis C virus; liver biopsy

Indexed keywords

ACTITEST; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC PROCEDURE; FEMALE; FIBROTEST; GOLD STANDARD; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MALE; NEEDLE BIOPSY; NONHUMAN; OUTCOME ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SERUM; SINGLE BLIND PROCEDURE; ANALYTICAL EQUIPMENT; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CYTOCHEMISTRY; EVALUATION; INFLAMMATION; LIVER CIRRHOSIS; METHODOLOGY; NECROSIS; PATHOLOGY; STATISTICS;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HISTOCYTOCHEMISTRY; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MALE; NECROSIS; REAGENT KITS, DIAGNOSTIC; SERUM; STATISTICS AS TOPIC;

EID: 77955899498     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68281     Document Type: Article

References (20)

1. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344: 495-500.
2. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002;36:S152-60.
3. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000;14:543-548
4. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97: 2614-2618
5. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457 (Pubitemid 37466971)
6. Bedossa P, Poynard T. An algorithm fort he grading of activity in chronic hepatitis C: The METAV̇R Cooperative Study Group. Hepatology 1996;24:289-293
7. Dirican A. Evaluation of the diagnostic test's performance and their comparisons. Cerrahpa̧a J Med 2001;32:25-30.
8. Güllüoǧlu MG., Özlük Y.,Öztürk AS, Demir D, Çevikbaş U. Interobserver agreement in the histologic scoring of chronic viral hepatitis. Turk J Pathol 2005;21:3-7.
9. The World Medical Association. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. Available from: http://www.wma.net/e/policy/b3.htm. [last retrived on 2005 Jul 26].
10. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8.
11. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, et al. Role of liver biopsy in management of Chronic hepatitis C: A systematic review. Hepatology 2002;36:S161-72.
12. Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003;38:481-492
13. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004;50:1344-1355
14. Munteanu M, Messous D, Thabut D, Imbert-Bismut F, Jouys M, Massard J, et al. İntraindividual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest). Comp Hepatol 2004;3:3.
15. Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatolol 2003;39:222-230 (Pubitemid 36920558)
16. Product information: Available from: http://www.vitaldp.com/v2/ noninvasiv. asp#x2 [last cited on 2009 Aug 20].
17. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynart T: MULṪVIRC Group. Biochemical markers of liver fibrosis in patients with hepatit C virus infection: A prospective study. Lancet 2001;357:1069-1075
18. Colleredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003;39:239-244
19. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457 (Pubitemid 37466971)
20. Riley TR 3rd, Ruggiero FM. The effect of processing on liver biopsy core size. Dig Dis Sci 2008;53:2775-2777